Literature DB >> 23291366

Functional cooperation of URAT1 (SLC22A12) and URATv1 (SLC2A9) in renal reabsorption of urate.

Takeo Nakanishi1, Kouhei Ohya, Sho Shimada, Naohiko Anzai, Ikumi Tamai.   

Abstract

BACKGROUND: Serum urate (SUA) level is affected by alteration in urinary reabsorption caused by clinically important drugs; however, there are no experimental models suitable to assess their effect on renal reabsorption. We, therefore, aimed to establish an experimental system co-expressing the urate transporters URAT1 (SLC22A12) and URATv1 (SLC2A9) (designated UUv cells) at the apical and basolateral membranes, respectively.
METHODS: Apical uptake and vectorial transport of [(14)C]urate in the apical-to-basolateral direction in UUv cells were measured in the presence or absence of uricosuric benzbromarone or anti-uricosuric trans-stimulators.
RESULTS: The urate permeability in the apical-to-basolateral direction remarkably increased by 7.0-fold in UUv cells, compared with non-transfected mock cells. The apical-to-basolateral transport was cis-inhibited by benzbromarone, but trans-stimulated by pyrazinecarboxylic acid and monocarboxylates such as nicotinate and lactate. Furthermore, salicylate showed both trans-stimulation and cis-inhibition in the urate transport at low and high concentrations, respectively. Finally, coexpression of URAT1 and URATv1 in human kidney epithelial cells was exhibited immunohistochemically.
CONCLUSIONS: It is demonstrated that functional cooperation of URAT1 and URATv1 is essential for renal reabsorption of urate, and in the established system influence of drugs on SUA is reflected in the alteration of urate permeability across the renal tubular epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23291366     DOI: 10.1093/ndt/gfs574

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

1.  Organic Anion Transporter 1 Deficiency Accelerates Learning and Memory Impairment in tg2576 Mice by Damaging Dendritic Spine Morphology and Activity.

Authors:  Xinlin Wu; Jianqing Zhang; Heng Liu; Yansheng Mian; Birong Liang; Hongbo Xie; Shijun Zhang; Baoguo Sun; Houming Zhou
Journal:  J Mol Neurosci       Date:  2015-03-01       Impact factor: 3.444

2.  Uric acid crystal could inhibit Numb-induced URAT1 lysosome degradation in uric acid nephropathy.

Authors:  Xinlin Wu; Jianqing Zhang; Taoli Liu; Miansheng Yan; Heng Liu; Hongbo Xie; Shijun Zhang; Baoguo Sun; Bin Ke; Houming Zhou
Journal:  J Physiol Biochem       Date:  2015-03-17       Impact factor: 4.158

3.  Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA-REG OUTCOME trial.

Authors:  João Pedro Ferreira; Silvio E Inzucchi; Michaela Mattheus; Thomas Meinicke; Dominik Steubl; Christoph Wanner; Bernard Zinman
Journal:  Diabetes Obes Metab       Date:  2021-10-04       Impact factor: 6.408

4.  Fucoidan from Laminaria japonica Inhibits Expression of GLUT9 and URAT1 via PI3K/Akt, JNK and NF-κB Pathways in Uric Acid-Exposed HK-2 Cells.

Authors:  Yu Zhang; Xiaohui Tan; Zhen Lin; Fangping Li; Chunyan Yang; Haiying Zheng; Lingyu Li; Huazhong Liu; Jianghua Shang
Journal:  Mar Drugs       Date:  2021-04-23       Impact factor: 5.118

5.  SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria.

Authors:  Yukihiro Chino; Yoshishige Samukawa; Soichi Sakai; Yasuhiro Nakai; Jun-ichi Yamaguchi; Takeo Nakanishi; Ikumi Tamai
Journal:  Biopharm Drug Dispos       Date:  2014-08-06       Impact factor: 1.627

6.  Mechanism of high affinity inhibition of the human urate transporter URAT1.

Authors:  Philip K Tan; Traci M Ostertag; Jeffrey N Miner
Journal:  Sci Rep       Date:  2016-10-07       Impact factor: 4.379

7.  Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia.

Authors:  Kei Nishizawa; Noriaki Yoda; Fumi Morokado; Hisakazu Komori; Takeo Nakanishi; Ikumi Tamai
Journal:  PLoS One       Date:  2019-04-05       Impact factor: 3.240

Review 8.  Modulation of Urate Transport by Drugs.

Authors:  Péter Tátrai; Franciska Erdő; Gabriella Dörnyei; Péter Krajcsi
Journal:  Pharmaceutics       Date:  2021-06-17       Impact factor: 6.321

Review 9.  Physiology of Hyperuricemia and Urate-Lowering Treatments.

Authors:  Caroline L Benn; Pinky Dua; Rachel Gurrell; Peter Loudon; Andrew Pike; R Ian Storer; Ciara Vangjeli
Journal:  Front Med (Lausanne)       Date:  2018-05-31

10.  Low Expression Levels of SLC22A12 Indicates a Poor Prognosis and Progresses Clear Cell Renal Cell Carcinoma.

Authors:  Jiaju Xu; Yuenan Liu; Jingchong Liu; Yi Shou; Zhiyong Xiong; Hairong Xiong; Tianbo Xu; Qi Wang; Di Liu; Huageng Liang; Hongmei Yang; Xiong Yang; Xiaoping Zhang
Journal:  Front Oncol       Date:  2021-06-23       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.